Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
WellAI is a private healthcare AI company that develops AI-driven digital health and diagnostic support software for patients, clinicians, and healthcare organizations. Founded in 2020 during the COVID-19 crisis, the company built a voice-guided digital health assistant and a provider-facing platform intended to support symptom triage, evidence-based diagnostic insight, documentation automation, chronic care management, and population health workflows. Its technology is described as drawing on more than 30 million medical journals and research publications to generate rapid health guidance and second-opinion style outputs. The company appears to operate commercially as a health-tech software vendor rather than as a therapeutics developer, with no conventional drug pipeline or disclosed clinical-stage assets. Its offerings are positioned to reduce provider burnout, improve patient intake and communication, and support employers and medical practices with digital health services.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on WellAI.